Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Dignass

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
United European Gastroenterology Journal|December 15, 2021
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysisFernando Magro, Catarina Alves, Mafalda Santiago, et al.
Digestion|January 5, 2008
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel diseaseDaniel C Baumgart, Carsten Buning, Lars Geerdts, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Expert Review of Gastroenterology & Hepatology|September 3, 2024
Practical management of mild-to-moderate ulcerative colitis: an international expert consensusFerdinando D'Amico, Fernando Magro, Axel Dignass, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel DiseaseAxel Dignass, Neeraj Narula, Krishan Pratap, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
Digestive Diseases and Sciences|November 8, 2025
Management of Patients with Ulcerative Proctitis: A Global SurveyBénédicte Caron, Léa Sequier, Axel Dignass, et al.
United European Gastroenterology Journal|December 16, 2020
Overcoming the barriers to dissemination and implementation of quality measures for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) position statementRaf Bisschops, Matthew D Rutter, Miguel Areia, et al.
United European Gastroenterology Journal|October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome frameworkPaula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
United European Gastroenterology Journal|December 15, 2021
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysisFernando Magro, Catarina Alves, Mafalda Santiago, et al.
Digestion|January 5, 2008
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel diseaseDaniel C Baumgart, Carsten Buning, Lars Geerdts, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Expert Review of Gastroenterology & Hepatology|September 3, 2024
Practical management of mild-to-moderate ulcerative colitis: an international expert consensusFerdinando D'Amico, Fernando Magro, Axel Dignass, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|March 9, 2026
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel DiseaseAxel Dignass, Neeraj Narula, Krishan Pratap, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
Digestive Diseases and Sciences|November 8, 2025
Management of Patients with Ulcerative Proctitis: A Global SurveyBénédicte Caron, Léa Sequier, Axel Dignass, et al.
United European Gastroenterology Journal|December 16, 2020
Overcoming the barriers to dissemination and implementation of quality measures for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and United European Gastroenterology (UEG) position statementRaf Bisschops, Matthew D Rutter, Miguel Areia, et al.
United European Gastroenterology Journal|October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome frameworkPaula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Pageof 18